US 7807383
Diagnosing and treating hormone resistant cancers
granted A61PA61P35/04
Quick answer
US patent 7807383 (Diagnosing and treating hormone resistant cancers) held by The Board of Regents of the University of Texas System expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/04